Hyzaar (Losartan Potassium, Hydrochlorothiazide)

Hyzaar is an antihypertensive medication that works within the renin‑angiotensin‑aldosterone system and diuretic pathways to lower blood pressure.

• Hypertension: reduces systolic and diastolic blood pressure in adults.
• Essential hypertension requiring combination therapy: provides added blood‑pressure control when monotherapy is insufficient.
• Hypertensive patients with fluid retention: adds a thiazide diuretic effect to decrease plasma volume and improve pressure control.

• Losartan potassium selectively blocks AT1 receptors for angiotensin II, preventing vasoconstriction and aldosterone release. Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, promoting diuresis and reducing extracellular fluid volume. Together, they lower systemic vascular resistance and plasma volume, resulting in decreased arterial pressure.

Hyzaar may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Dizziness or light‑headedness.
• Headache.
• Fatigue.
• Increased urination.
• Electrolyte disturbances (e.g., low potassium).
• Mild gastrointestinal upset.

Serious or Rare Side Effects

• Severe hypotension.
• Acute kidney injury.
• Hyperkalemia.
• Angioedema.
• Severe allergic reactions (rash, itching, swelling).
• Liver function abnormalities.

Before initiating Hyzaar, consider patient‑specific factors and monitor appropriately.

• Renal impairment: assess kidney function and adjust therapy as needed.
• Electrolyte balance: monitor serum potassium and sodium levels.
• Hepatic disease: use with caution in patients with liver dysfunction.
• Concomitant medications: review for potential interactions that affect blood pressure or electrolytes.
• Pregnancy: avoid use unless clearly needed; discuss risks with a healthcare professional.
• Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and light.

Hyzaar can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Potassium‑sparing diuretics or supplements: risk of hyperkalemia.
• ACE inhibitors or aliskiren: may cause excessive renal dysfunction.
• NSAIDs: can blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely)

• Lithium: increased lithium levels, monitor serum concentration.
• Antidiabetic agents: may enhance hypoglycemic effect.
• Other antihypertensives: additive blood‑pressure lowering, watch for hypotension.